1. Home
  2. VCEL vs BUR Comparison

VCEL vs BUR Comparison

Compare VCEL & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$33.58

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Burford Capital Limited

BUR

Burford Capital Limited

HOLD

Current Price

$4.38

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
BUR
Founded
1989
2009
Country
United States
Guernsey
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
VCEL
BUR
Price
$33.58
$4.38
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$58.50
$13.58
AVG Volume (30 Days)
742.6K
6.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
2.84%
EPS Growth
60.00
N/A
EPS
0.32
0.28
Revenue
$276,259,000.00
$413,360,000.00
Revenue This Year
$19.10
$73.90
Revenue Next Year
$17.95
$5.52
P/E Ratio
$104.91
$15.73
Revenue Growth
16.45
N/A
52 Week Low
$28.95
$3.59
52 Week High
$45.97
$14.61

Technical Indicators

Market Signals
Indicator
VCEL
BUR
Relative Strength Index (RSI) 51.53 26.03
Support Level $31.24 $3.59
Resistance Level $34.77 $9.79
Average True Range (ATR) 1.66 0.60
MACD 0.39 -0.10
Stochastic Oscillator 74.14 17.72

Price Performance

Historical Comparison
VCEL
BUR

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About BUR Burford Capital Limited

Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.

Share on Social Networks: